Terns Pharmaceuticals, Inc. · NASDAQ:TERN
Commodore Capital LP reported a 5.30% stake in Terns Pharmaceuticals, Inc. (Schedule 13G)
Event Sep 9, 2025 · Filed Sep 16, 2025
Commodore Capital LP reported a 5.30% stake in Terns Pharmaceuticals, Inc., 4,650,000 shares, as a passive investor on Sep 9, 2025. Filed Sep 16, 2025 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 4,650,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 5.30% | 4,650,000 |
| Commodore Capital Master LP | 5.30% | 4,650,000 |
| Robert Egen Atkinson | 5.30% | 4,650,000 |
| Michael Kramarz | 5.30% | 4,650,000 |
Source
Related
- Terns Pharmaceuticals, Inc.
- Commodore Capital LP
- Terns Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Feb 17, 2026
- Schedule 13G/A · Commodore Capital LP · Nov 14, 2025
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Form 4 · Kuriakose Emil · May 5, 2026
- Form 4 · Gengos Andrew · May 5, 2026